Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Tigecycline Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Tigecycline Market Overview

    • 1.1 Product Overview and Scope of Tigecycline
    • 1.2 Tigecycline Segment by Type
      • 1.2.1 Global Tigecycline Sales Growth Rate Comparison by Type (2021-2026)
      • 1.2.2 Gram Positive Bacteria
      • 1.2.3 Gram Negative Bacteria
    • 1.3 Tigecycline Segment by Application
      • 1.3.1 Tigecycline Sales Comparison by Application: 2020 VS 2026
      • 1.3.2 Skin & Soft Tissue Infections
      • 1.3.3 Complicated Intra-abdominal Infections
      • 1.3.4 Community-acquired Bacterial Pneumonia
    • 1.4 Global Tigecycline Market Size Estimates and Forecasts
      • 1.4.1 Global Tigecycline Revenue 2015-2026
      • 1.4.2 Global Tigecycline Sales 2015-2026
      • 1.4.3 Tigecycline Market Size by Region: 2020 Versus 2026

    2 Global Tigecycline Market Competition by Manufacturers

    • 2.1 Global Tigecycline Sales Market Share by Manufacturers (2015-2020)
    • 2.2 Global Tigecycline Revenue Share by Manufacturers (2015-2020)
    • 2.3 Global Tigecycline Average Price by Manufacturers (2015-2020)
    • 2.4 Manufacturers Tigecycline Manufacturing Sites, Area Served, Product Type
    • 2.5 Tigecycline Market Competitive Situation and Trends
      • 2.5.1 Tigecycline Market Concentration Rate
      • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
      • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
    • 2.7 Primary Interviews with Key Tigecycline Players (Opinion Leaders)

    3 Tigecycline Retrospective Market Scenario by Region

    • 3.1 Global Tigecycline Retrospective Market Scenario in Sales by Region: 2015-2020
    • 3.2 Global Tigecycline Retrospective Market Scenario in Revenue by Region: 2015-2020
    • 3.3 North America Tigecycline Market Facts & Figures by Country
      • 3.3.1 North America Tigecycline Sales by Country
      • 3.3.2 North America Tigecycline Sales by Country
      • 3.3.3 U.S.
      • 3.3.4 Canada
    • 3.4 Europe Tigecycline Market Facts & Figures by Country
      • 3.4.1 Europe Tigecycline Sales by Country
      • 3.4.2 Europe Tigecycline Sales by Country
      • 3.4.3 Germany
      • 3.4.4 France
      • 3.4.5 U.K.
      • 3.4.6 Italy
      • 3.4.7 Russia
    • 3.5 Asia Pacific Tigecycline Market Facts & Figures by Region
      • 3.5.1 Asia Pacific Tigecycline Sales by Region
      • 3.5.2 Asia Pacific Tigecycline Sales by Region
      • 3.5.3 China
      • 3.5.4 Japan
      • 3.5.5 South Korea
      • 3.5.6 India
      • 3.5.7 Australia
      • 3.5.8 Taiwan
      • 3.5.9 Indonesia
      • 3.5.10 Thailand
      • 3.5.11 Malaysia
      • 3.5.12 Philippines
      • 3.5.13 Vietnam
    • 3.6 Latin America Tigecycline Market Facts & Figures by Country
      • 3.6.1 Latin America Tigecycline Sales by Country
      • 3.6.2 Latin America Tigecycline Sales by Country
      • 3.6.3 Mexico
      • 3.6.3 Brazil
      • 3.6.3 Argentina
    • 3.7 Middle East and Africa Tigecycline Market Facts & Figures by Country
      • 3.7.1 Middle East and Africa Tigecycline Sales by Country
      • 3.7.2 Middle East and Africa Tigecycline Sales by Country
      • 3.7.3 Turkey
      • 3.7.4 Saudi Arabia
      • 3.7.5 U.A.E

    4 Global Tigecycline Historic Market Analysis by Type

    • 4.1 Global Tigecycline Sales Market Share by Type (2015-2020)
    • 4.2 Global Tigecycline Revenue Market Share by Type (2015-2020)
    • 4.3 Global Tigecycline Price Market Share by Type (2015-2020)
    • 4.4 Global Tigecycline Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

    5 Global Tigecycline Historic Market Analysis by Application

    • 5.1 Global Tigecycline Sales Market Share by Application (2015-2020)
    • 5.2 Global Tigecycline Revenue Market Share by Application (2015-2020)
    • 5.3 Global Tigecycline Price by Application (2015-2020)

    6 Company Profiles and Key Figures in Tigecycline Business

    • 6.1 Pfizer
      • 6.1.1 Corporation Information
      • 6.1.2 Pfizer Description, Business Overview and Total Revenue
      • 6.1.3 Pfizer Tigecycline Sales, Revenue and Gross Margin (2015-2020)
      • 6.1.4 Pfizer Products Offered
      • 6.1.5 Pfizer Recent Development
    • 6.2 Hisun Pharma
      • 6.2.1 Hisun Pharma Tigecycline Production Sites and Area Served
      • 6.2.2 Hisun Pharma Description, Business Overview and Total Revenue
      • 6.2.3 Hisun Pharma Tigecycline Sales, Revenue and Gross Margin (2015-2020)
      • 6.2.4 Hisun Pharma Products Offered
      • 6.2.5 Hisun Pharma Recent Development
    • 6.3 Hansoh Pharma
      • 6.3.1 Hansoh Pharma Tigecycline Production Sites and Area Served
      • 6.3.2 Hansoh Pharma Description, Business Overview and Total Revenue
      • 6.3.3 Hansoh Pharma Tigecycline Sales, Revenue and Gross Margin (2015-2020)
      • 6.3.4 Hansoh Pharma Products Offered
      • 6.3.5 Hansoh Pharma Recent Development
    • 6.4 Jiagsu Aosaikang Pharmaceutical
      • 6.4.1 Jiagsu Aosaikang Pharmaceutical Tigecycline Production Sites and Area Served
      • 6.4.2 Jiagsu Aosaikang Pharmaceutical Description, Business Overview and Total Revenue
      • 6.4.3 Jiagsu Aosaikang Pharmaceutical Tigecycline Sales, Revenue and Gross Margin (2015-2020)
      • 6.4.4 Jiagsu Aosaikang Pharmaceutical Products Offered
      • 6.4.5 Jiagsu Aosaikang Pharmaceutical Recent Development
    • 6.5 HICIN Pharma
      • 6.5.1 HICIN Pharma Tigecycline Production Sites and Area Served
      • 6.5.2 HICIN Pharma Description, Business Overview and Total Revenue
      • 6.5.3 HICIN Pharma Tigecycline Sales, Revenue and Gross Margin (2015-2020)
      • 6.5.4 HICIN Pharma Products Offered
      • 6.5.5 HICIN Pharma Recent Development
    • 6.6 Abbott Laboratories
      • 6.6.1 Abbott Laboratories Tigecycline Production Sites and Area Served
      • 6.6.2 Abbott Laboratories Description, Business Overview and Total Revenue
      • 6.6.3 Abbott Laboratories Tigecycline Sales, Revenue and Gross Margin (2015-2020)
      • 6.6.4 Abbott Laboratories Products Offered
      • 6.6.5 Abbott Laboratories Recent Development
    • 6.7 Amgen
      • 6.6.1 Amgen Tigecycline Production Sites and Area Served
      • 6.6.2 Amgen Description, Business Overview and Total Revenue
      • 6.6.3 Amgen Tigecycline Sales, Revenue and Gross Margin (2015-2020)
      • 6.4.4 Amgen Products Offered
      • 6.7.5 Amgen Recent Development
    • 6.8 Astrazeneca
      • 6.8.1 Astrazeneca Tigecycline Production Sites and Area Served
      • 6.8.2 Astrazeneca Description, Business Overview and Total Revenue
      • 6.8.3 Astrazeneca Tigecycline Sales, Revenue and Gross Margin (2015-2020)
      • 6.8.4 Astrazeneca Products Offered
      • 6.8.5 Astrazeneca Recent Development
    • 6.9 Merck
      • 6.9.1 Merck Tigecycline Production Sites and Area Served
      • 6.9.2 Merck Description, Business Overview and Total Revenue
      • 6.9.3 Merck Tigecycline Sales, Revenue and Gross Margin (2015-2020)
      • 6.9.4 Merck Products Offered
      • 6.9.5 Merck Recent Development
    • 6.10 Novartis
      • 6.10.1 Novartis Tigecycline Production Sites and Area Served
      • 6.10.2 Novartis Description, Business Overview and Total Revenue
      • 6.10.3 Novartis Tigecycline Sales, Revenue and Gross Margin (2015-2020)
      • 6.10.4 Novartis Products Offered
      • 6.10.5 Novartis Recent Development
    • 6.11 Roche Holdings
      • 6.11.1 Roche Holdings Tigecycline Production Sites and Area Served
      • 6.11.2 Roche Holdings Tigecycline Description, Business Overview and Total Revenue
      • 6.11.3 Roche Holdings Tigecycline Sales, Revenue and Gross Margin (2015-2020)
      • 6.11.4 Roche Holdings Products Offered
      • 6.11.5 Roche Holdings Recent Development
    • 6.12 Johnson & Johnson
      • 6.12.1 Johnson & Johnson Tigecycline Production Sites and Area Served
      • 6.12.2 Johnson & Johnson Tigecycline Description, Business Overview and Total Revenue
      • 6.12.3 Johnson & Johnson Tigecycline Sales, Revenue and Gross Margin (2015-2020)
      • 6.12.4 Johnson & Johnson Products Offered
      • 6.12.5 Johnson & Johnson Recent Development
    • 6.13 Sanofi
      • 6.13.1 Sanofi Tigecycline Production Sites and Area Served
      • 6.13.2 Sanofi Tigecycline Description, Business Overview and Total Revenue
      • 6.13.3 Sanofi Tigecycline Sales, Revenue and Gross Margin (2015-2020)
      • 6.13.4 Sanofi Products Offered
      • 6.13.5 Sanofi Recent Development
    • 6.14 Lifecare Innovations
      • 6.14.1 Lifecare Innovations Tigecycline Production Sites and Area Served
      • 6.14.2 Lifecare Innovations Tigecycline Description, Business Overview and Total Revenue
      • 6.14.3 Lifecare Innovations Tigecycline Sales, Revenue and Gross Margin (2015-2020)
      • 6.14.4 Lifecare Innovations Products Offered
      • 6.14.5 Lifecare Innovations Recent Development
    • 6.15 Progen Nutraceuticals
      • 6.15.1 Progen Nutraceuticals Tigecycline Production Sites and Area Served
      • 6.15.2 Progen Nutraceuticals Tigecycline Description, Business Overview and Total Revenue
      • 6.15.3 Progen Nutraceuticals Tigecycline Sales, Revenue and Gross Margin (2015-2020)
      • 6.15.4 Progen Nutraceuticals Products Offered
      • 6.15.5 Progen Nutraceuticals Recent Development

    7 Tigecycline Manufacturing Cost Analysis

    • 7.1 Tigecycline Key Raw Materials Analysis
      • 7.1.1 Key Raw Materials
      • 7.1.2 Key Raw Materials Price Trend
      • 7.1.3 Key Suppliers of Raw Materials
    • 7.2 Proportion of Manufacturing Cost Structure
    • 7.3 Manufacturing Process Analysis of Tigecycline
    • 7.4 Tigecycline Industrial Chain Analysis

    8 Marketing Channel, Distributors and Customers

    • 8.1 Marketing Channel
    • 8.2 Tigecycline Distributors List
    • 8.3 Tigecycline Customers

    9 Market Dynamics

    • 9.1 Market Trends
    • 9.2 Opportunities and Drivers
    • 9.3 Challenges
    • 9.4 Porter's Five Forces Analysis

    10 Global Market Forecast

    • 10.1 Global Tigecycline Market Estimates and Projections by Type
      • 10.1.1 Global Forecasted Sales of Tigecycline by Type (2021-2026)
      • 10.1.2 Global Forecasted Revenue of Tigecycline by Type (2021-2026)
    • 10.2 Tigecycline Market Estimates and Projections by Application
      • 10.2.1 Global Forecasted Sales of Tigecycline by Application (2021-2026)
      • 10.2.2 Global Forecasted Revenue of Tigecycline by Application (2021-2026)
    • 10.3 Tigecycline Market Estimates and Projections by Region
      • 10.3.1 Global Forecasted Sales of Tigecycline by Region (2021-2026)
      • 10.3.2 Global Forecasted Revenue of Tigecycline by Region (2021-2026)
    • 10.4 North America Tigecycline Estimates and Projections (2021-2026)
    • 10.5 Europe Tigecycline Estimates and Projections (2021-2026)
    • 10.6 Asia Pacific Tigecycline Estimates and Projections (2021-2026)
    • 10.7 Latin America Tigecycline Estimates and Projections (2021-2026)
    • 10.8 Middle East and Africa Tigecycline Estimates and Projections (2021-2026)

    11 Research Finding and Conclusion

      12 Methodology and Data Source

      • 12.1 Methodology/Research Approach
        • 12.1.1 Research Programs/Design
        • 12.1.2 Market Size Estimation
        • 12.1.3 Market Breakdown and Data Triangulation
      • 12.2 Data Source
        • 12.2.1 Secondary Sources
        • 12.2.2 Primary Sources
      • 12.3 Author List

      This report focuses on Tigecycline volume and value at global level, regional level and company level. From a global perspective, this report represents overall Tigecycline market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
      At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

      The following manufacturers are covered:
      Pfizer
      Hisun Pharma
      Hansoh Pharma
      Jiagsu Aosaikang Pharmaceutical
      HICIN Pharma
      Abbott Laboratories
      Amgen
      Astrazeneca
      Merck
      Novartis
      Roche Holdings
      Johnson & Johnson
      Sanofi
      Lifecare Innovations
      Progen Nutraceuticals

      Segment by Regions
      North America
      Europe
      China
      Japan

      Segment by Type
      Gram Positive Bacteria
      Gram Negative Bacteria

      Segment by Application
      Skin & Soft Tissue Infections
      Complicated Intra-abdominal Infections
      Community-acquired Bacterial Pneumonia
      Buy now